Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
BMC Med Genomics ; 17(1): 151, 2024 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-38831290

RESUMEN

BACKGROUND: Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disease caused by biallelic variants in the N-acetylgalactosamine-6-sulfatase (GALNS) gene and is characterized by progressive and multi-system involvements, dominantly with skeletal deformities. A mild form of MPS IVA often presents with atypical symptoms and can go unrecognized for years. METHODS: The diagnosis of MPS IVA was confirmed via GALNS enzyme activity testing in leukocytes. Clinical features were collected. Molecular analysis was performed by next generation sequence and Sanger sequencing of the GALNS gene. The pathogenicity of the deep intron variant was verified by mRNA analyses. RESULTS: Thirteen patients with mild MPS IVA from six families were included. All probands first visit pediatric orthopedists and it took 5.6 years to be diagnosed after the disease onset. The most common symptoms in our series were waddling gait (85%), short neck (69%) and flat feet (62%). Radiologic findings indicated skeletal abnormalities in all patients, especially modification of the vertebral bodies (100%) and acetabular and femoral head dysplasia (100%). Five novel GALNS variants, including c.121-2_121-1insTTTGCTGGCATATGCA, E2 deletion, c.569 A > G, c.898 + 2 T > A, and c.1139 + 2 T > C, were identified. The most common variant, a deep intron variant NM_000512.5: c.121-210 C > T (NM_001323544.2: c.129 C > T, p.G43G), was revealed to result in an 11 bp deletion (c.128_138delGCGATGCTGAG, p.Gly43Aspfs*5) on GALNS mRNA in the GALNS transcript of NM_001323544.2. CONCLUSIONS: This study provides significant insights into the clinical features and molecular characteristics that contribute to the early diagnosis of mild MPS IVA. On the basis of our cohort, orthopedists need to be able to recognize signs and symptoms of mild MPS IVA as well as the molecular and biochemical diagnosis so that an early diagnosis and treatment can be instituted.


Asunto(s)
Diagnóstico Tardío , Mucopolisacaridosis IV , Humanos , Masculino , Mucopolisacaridosis IV/genética , Mucopolisacaridosis IV/diagnóstico , Niño , Femenino , Preescolar , Adolescente , Condroitinsulfatasas/genética , Mutación
2.
Int J Mol Sci ; 25(6)2024 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-38542208

RESUMEN

Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome) is a rare autosomal recessive lysosomal storage disease (LSD) caused by deficiency of a hydrolase enzyme, N-acetylgalactosamine-6-sulfate sulfatase, and characterized clinically by mainly musculoskeletal manifestations. The mechanisms underlying bone involvement in humans are typically explored using invasive techniques such as bone biopsy, which complicates analysis in humans. We compared bone proteomes using DDA and SWATH-MS in wild-type and MPS IVA knockout mice (UNT) to obtain mechanistic information about the disease. Our findings reveal over 1000 dysregulated proteins in knockout mice, including those implicated in oxidative phosphorylation, oxidative stress (reactive oxygen species), DNA damage, and iron transport, and suggest that lactate dehydrogenase may constitute a useful prognostic and follow-up biomarker. Identifying biomarkers that reflect MPS IVA clinical course, severity, and progression have important implications for disease management.


Asunto(s)
Enfermedades Óseas , Enfermedades de los Cartílagos , Condroitinsulfatasas , Mucopolisacaridosis IV , Humanos , Animales , Ratones , Mucopolisacaridosis IV/metabolismo , Condroitinsulfatasas/genética , Ratones Noqueados
3.
P R Health Sci J ; 42(4): 332-334, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38104293

RESUMEN

Mucopolysaccharidosis (MPS) is a metabolic disorder resulting from a deficiency of lysosomal enzymes. It is an autosomal recessive disorder with similar incidences in men and women. Mucopolysaccharidosis type IV A is caused by a deficiency of N-acetylgalactosamine-6-sulfatase, which deficiency is, in turn, caused by alterations in the GALNS gene. It is marked by a short stature, a pigeon chest, frontal bossing, kyphosis, and a flat nasal bridge. Intraorally, macroglossia, hypodontia, dentinogenesis imperfecta, a broad mouth, and an anterior open bite are some of the common features. The present paper reports on a case of MPS in a 5-year-old male patient, along with providing a review of the literature and insight into the oral manifestations related to MPS IV A, also called Morquio A syndrome, and its dental treatment. It aims to highlight the clinical recommendations for oral health care in such cases during different phases of MPS IV A treatment.


Asunto(s)
Condroitinsulfatasas , Mucopolisacaridosis IV , Masculino , Humanos , Niño , Femenino , Preescolar , Mucopolisacaridosis IV/genética , Mucopolisacaridosis IV/terapia , Condroitinsulfatasas/genética , Condroitinsulfatasas/metabolismo , Atención a la Salud
4.
Rev. Inst. Med. Trop. Säo Paulo ; 49(4): 203-206, Jul.-Aug. 2007. tab
Artículo en Inglés | LILACS | ID: lil-460224

RESUMEN

Candida dubliniensis is an opportunistic yeast that has been recovered from several body sites in many populations; it is most often recovered from the oral cavities of human immunodeficiency virus-infected patients. Although extensive studies on epidemiology and phylogeny of C. dubliniensis have been performed, little is known about virulence factors such as exoenzymatic and hemolytic activities. In this study we compared proteinase, hyaluronidase, chondroitin sulphatase and hemolytic activities in 18 C. dubliniensis and 30 C. albicans strains isolated from AIDS patients. C. albicans isolates produced higher amounts of proteinase than C. dubliniensis (p < 0.05). All the tested C. dubliniensis strains expressed hyaluronidase and chondroitin sulphatase activities, but none of them were significantly different from those observed with C. albicans (p > 0.05). Hemolytic activity was affected by CaCl2; when this component was absent, we did not notice any significant difference between C. albicans and C. dubliniensis hemolytic activities. On the contrary, when we added 2.5 g percent CaCl2, the hemolytic activity was reduced on C. dubliniensis and stimulated on C. albicans tested strains (p < 0.05).


C. dubliniensis é uma levedura oportunista que, embora já tenha sido isolada de vários sítios anatômicos é, com maior frequência, encontrada na boca de pacientes infectados pelo HIV. Embora tenham sido realizados numerosos estudos sobre a epidemiologia e filogenia, seus fatores de virulência como atividade exoenzimática e atividade hemolítica, são, ainda, pouco conhecidos. Neste estudo comparou-se a atividade in vitro de proteinase, hialuronidase, condroitin sulfatase e atividade hemolítica de 18 cultivos de C. dubliniensis com 30 cultivos de C. albicans, todos isolados de pacientes com SIDA. Foi evidenciada maior atividade de proteinase em C. albicans em relação a C. dubliniensis (p < 0,05). Todos os isolados de C. dubliniensis evidenciaram atividade de hialuronidase e condroitin-sulfatase de forma similar ao observado com C. albicans (p > 0,05). Constatou-se que a atividade hemolítica foi influenciada pelo CaCl2; em sua ausência não foram observadas diferenças na atividade hemolítica das duas espécies; todavia, ao se agregar 2,5 por cento de CaCl2, a atividade hemolítica de C. dubliniensis foi reduzida enquanto a de C. albicans, estimulada (p < 0,05).


Asunto(s)
Humanos , Candida/enzimología , Condroitinsulfatasas/biosíntesis , Proteínas Hemolisinas/biosíntesis , Hialuronoglucosaminidasa/biosíntesis , Péptido Hidrolasas/biosíntesis , Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Candida albicans/enzimología , Candida/clasificación , Candida/aislamiento & purificación , Candida/patogenicidad , Factores de Virulencia
5.
Braz. j. med. biol. res ; 27(9): 2103-8, Sept. 1994. tab, ilus
Artículo en Inglés | LILACS | ID: lil-144463

RESUMEN

1. Two proteoglycans, PG1 and PG2, have been isolated from shark cartilage. Both are highly polydisperse and large (molecular mass: 1-10 x 10**6 Daltons) and contain chondroitin sulfate and keratan sulfate side chains, but PG2 is somewhat smaller tham PG1 and contains less keratan sulfate. 2. Monoclonal antibodies were raised against PG1. Many antibodies were obtained and one of them, MST1, was subcloned and furter characterized. This monoclonal antibody reacts with PG1 and PG2 from shark cartilage and also with aggrecan from bovine trachea cartilage. Chondroitinase AC-treated proteglycans react MST1, indicating that the antibody does not reconize chondroitin sulfate. MST1 also recognizes aggrecan from human cartilage and a proteoglycan from bovine brain (neurocan) but it does reconize proteoglycans from rat Walker tumor, fetal calf muscle and decorin from human myoma. 3. Using MST1 we were able to demonstrate that both PG1 aggregate with hyaluronic acid


Asunto(s)
Bovinos , Ratones , Conejos , Ratas , Humanos , Animales , Masculino , Anticuerpos Monoclonales/aislamiento & purificación , Cartílago/química , Proteoglicanos/química , Anticuerpos Monoclonales/biosíntesis , Anticuerpos Monoclonales/inmunología , Condroitinsulfatasas/química , Condroitinsulfatasas/inmunología , Condroitinsulfatasas/aislamiento & purificación , Epítopos , Sulfato de Queratano/química , Sulfato de Queratano/inmunología , Sulfato de Queratano/aislamiento & purificación , Proteoglicanos/inmunología , Proteoglicanos/aislamiento & purificación
6.
Rev. microbiol ; 19(4): 442-5, out.-dez. 1988. tab
Artículo en Portugués | LILACS | ID: lil-69602

RESUMEN

Verificou-se a produçäo de hialuronidase, condroitin sulfatase, lecitinase e gelatinase, por amostras de leveduras do gênero Candida, isoladas da cavidade bucal. Todas as amostras de C. albicans, produziram hialuronidase e condroitin sulfatase, mas näo lecitinase e gelatinase. Das 17 amostras de C. parapsilosis testadas, apenas 2 produziram lecitinase e 4 produziram gelatinase. C. tropicalis e C. guillermondi, näo produziram qualquer das enzimas estudadas


Asunto(s)
Fosfolipasas/metabolismo , Candida albicans/enzimología , Condroitinsulfatasas/metabolismo , Hialuronoglucosaminidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA